We are live on ! Find out more
Covestor

Covestor Portfolio holdings

AUM $157M Turnover 12.63%
1-Year Est. Return 35.87%
This Fund
S&P 500
This Quarter Est. Return
-1.73%
1 Year Est. Return
+35.87%
3 Year Est. Return
+134.26%
5 Year Est. Return
+155%
10 Year Est. Return
–
AUM
$157M
AUM Growth
-$16.3M
Cap. Flow
-$5.99M
Cap. Flow %
-3.82%
Top 10 Hldgs %
14.08%
Holding
2,984
New
164
Increased
994
Reduced
1,456
Closed
213
Avg Time Held Equity + Options
3.6 years
Top 10 Avg Time Held Equity + Options
1.6 years
Top 20 Avg Time Held Equity + Options
1.9 years
Avg Time Held Equity only
3.6 years
Top 10 Avg Time Held Equity only
1.6 years
Top 20 Avg Time Held Equity only
1.9 years

Top Buys

Rank Stock Value
1
TRIP icon
TripAdvisor
TRIP
+$1.1M
2
CORZ icon
Core Scientific
CORZ
+$987K
3
CIFR icon
Cipher Digital
CIFR
+$914K
4
AXTI icon
AXT
AXTI
+$687K
5
FIX icon
Comfort Systems
FIX
+$670K

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Miscellaneous 20.56%
3 Industrials 11.59%
4 Financials 11.1%
5 Healthcare 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AKTS icon
2926
Aktis Oncology
AKTS
$901M
$0 ﹤0.01%
10
-13
-57% -$316
2026 Q2
1 quarter
YSS icon
2927
York Space Systems
YSS
$495M
$0 ﹤0.01%
20
-2
-9% -$26
2026 Q2
1 quarter
BOBS icon
2928
Bobs Discount Furniture
BOBS
$2.59B
$0 ﹤0.01%
+22
New –
2026 Q3
0 quarters
INFQ icon
2929
Infleqtion
INFQ
$1.43B
$0 ﹤0.01%
+33
New –
2026 Q3
0 quarters
SHAZ icon
2930
SharonAI Holdings
SHAZ
$648M
$0 ﹤0.01%
4
-3,259
-100% -$198K
2026 Q2
1 quarter
GENB icon
2931
Generate Biomedicines
GENB
$1.23B
$0 ﹤0.01%
+21
New –
2026 Q3
0 quarters
DRAM icon
2932
Roundhill Memory ETF
DRAM
$15.7B
– –
-595
Closed -$44K –
ALMR icon
2933
Alamar Biosciences
ALMR
$1.84B
$0 ﹤0.01%
+11
New –
2026 Q3
0 quarters
KLRA icon
2934
Kailera Therapeutics
KLRA
$1.43B
$0 ﹤0.01%
+18
New –
2026 Q3
0 quarters
TRAX icon
2935
First Tracks Biotherapeutics
TRAX
$1.75B
$0 ﹤0.01%
13
-16
-55% -$625
2026 Q2
1 quarter
FNRN icon
2936
First Northern Community Bancorp
FNRN
$276M
$0 ﹤0.01%
+23
New –
2026 Q3
0 quarters
AVLN icon
2937
Avalyn Pharma
AVLN
$1.26B
$0 ﹤0.01%
+9
New –
2026 Q3
0 quarters

Similar funds

Covestor's Q3 2026 Portfolio in Review

As of Q3 2026, Covestor held 2,984 positions worth $157M, down 9.4% from $173M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Covestor withdrew a net $5.99M in Q3 2026, closing 213 positions and reducing 1,456 holdings. Its most notable exit was Abivax, an estimated $902K position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Industrials.

Against the trend, Covestor opened a new position in AXT worth $825K.

  • Covestor's largest Q3 2026 buy was AXT: 10,650 shares worth $825K.
  • Covestor added most to TripAdvisor in Q3 2026, an estimated $1.1M increase.
  • Covestor's biggest Q3 2026 reduction was Galaxy Digital, cutting an estimated $1.54M.
  • Covestor fully exited Abivax in Q3 2026, selling an estimated $902K.
  • Covestor's ten largest holdings make up 14% of its $157M portfolio in Q3 2026.
  • Covestor opened 164 new positions and closed 213 in Q3 2026.
  • Covestor's portfolio value fell 9.4% quarter-over-quarter to $157M.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.